海角天涯社区

Home＜ News & Events

News & Events

News Events Media Attention Partner News

Exploring the Dark Horse in the ADC CDMO Field：TOT Biopharm's (01875.HK) continuous performance growth attracted attention

A Biotech decided to fully turn into CDMO

What we can learn from the success of TOT BIOPHARM transformed into a CDMO company ?

On a journey to recovery, TOT BIOPHARM-B (01875.HK) establishes core competitive advantages to capture the lead of the industry

Revenue increased nearly fivefold and cash flows from operating activities turned positive, revealed TOT BIOPHARM-B (01875) achieved remarkable results in strategic transformation

ADC enjoys a promising future! TOT BIOPHARM's differentiated CDMO strategy achieved initially, cash flow turns positive for the first time!

CDMO transformation and upgrading proved effective, TOT BIOPHARM-B (1875.HK) embraces opportunities prospective strategic adjustment

TOT BIOPHARM-B (1875.HK) releases quality growth potential steadily, cash flows from operating activities turned positive for the first time!

ADC heat brings new opportunities, lack of professional CDMO supplier triggers capacity battle

海角天涯社区